Right ventricular failure after left ventricular assist device (LVAD) insertion is associated with significant mortality and morbidity. Mechanical support options include right ventricular assist devices, venoarterial extracorporeal membrane oxygenation (ECMO) and venopulmonary artery ECMO, the latter often involving central cannulation. We sought to evaluate the feasibility and early outcomes of a truly percutaneous venopulmonary artery (pVPA) ECMO strategy, with the potential advantage of bedside removal once weaned.

中文翻译：

---

左心室辅助装置插入后右心衰竭的经皮静脉肺动脉体外膜肺氧合

左心室辅助装置 (LVAD) 插入后的右心室衰竭与显着的死亡率和发病率相关。机械支持选择包括右心室辅助装置、静脉动脉体外膜肺氧合 (ECMO) 和静脉肺动脉 ECMO，后者通常涉及中心插管。我们试图评估真正经皮静脉肺动脉 (pVPA) ECMO 策略的可行性和早期结果，一旦断奶，床边移除的潜在优势。